InvestorsHub Logo
Followers 19
Posts 1300
Boards Moderated 0
Alias Born 04/03/2020

Re: justdafactss post# 228782

Tuesday, 01/09/2024 9:38:01 AM

Tuesday, January 09, 2024 9:38:01 AM

Post# of 233761
Take your own advice. Leronlimab did better than placebo in the primary endpoint of the study. Yes or no?

Now, don't lie. Also, you're purposely "confusing" or conflating the facts. Placebo did "better" in mortality percentage? Is that what you're trying to tell everyone?
I'd like my death percentage to go down, not up. Are you saying placebo was better because the percentage numbers are higher? There's nothing on page 7 that says placebo did better. Please post whatever it is your babbling about directly and not just the link.

The below table summarizes Day 28 all-cause mortality for combined and subgroups by age:

Table 1-1: Effect of Randomization by Age on 28-Day All-Cause Mortality

Death/Randomized (%) AbsoluteReduction Relative Reduction
Leronlimab Placebo

Day 28 Mortality, mITT 53/259 (20.5%) 27/125 (21.6%) 1.1% 5.3%

Day 28 Mortality, mITT, > 65y 36/88 (40.9%) 13/29 (44.8%) 3.9% 8.7%

Day 28 Mortality, mITT, £ 65y 17/171 (9.9%) 14/96 (14.6%) 4.7% 31.8%


Don't believe everything you read on the internet.
- Abraham Lincoln

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News